Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
41.47
Dollar change
+0.08
Percentage change
0.19
%
IndexRUT P/E- EPS (ttm)-3.97 Insider Own30.20% Shs Outstand97.88M Perf Week-0.17%
Market Cap4.06B Forward P/E- EPS next Y-3.07 Insider Trans-14.02% Shs Float68.32M Perf Month25.10%
Income-257.40M PEG- EPS next Q-0.72 Inst Own68.24% Short Float13.28% Perf Quarter75.35%
Sales0.00M P/S- EPS this Y23.78% Inst Trans-2.79% Short Ratio7.32 Perf Half Y155.83%
Book/sh5.49 P/B7.55 EPS next Y-1.91% ROA-63.48% Short Interest9.08M Perf Year269.28%
Cash/sh4.63 P/C8.95 EPS next 5Y- ROE-71.50% 52W Range6.40 - 44.33 Perf YTD211.80%
Dividend Est.- P/FCF- EPS past 5Y-106.26% ROI-51.49% 52W High-6.45% Beta1.08
Dividend TTM- Quick Ratio21.83 Sales past 5Y0.00% Gross Margin- 52W Low547.97% ATR (14)2.06
Dividend Ex-Date- Current Ratio21.83 EPS Y/Y TTM-18.88% Oper. Margin0.00% RSI (14)64.66 Volatility5.33% 5.51%
Employees141 Debt/Eq0.06 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price46.30
Option/ShortYes / Yes LT Debt/Eq0.05 EPS Q/Q-3.25% Payout- Rel Volume0.43 Prev Close41.39
Sales Surprise-100.00% EPS Surprise-1.25% Sales Q/Q- EarningsMay 02 AMC Avg Volume1.24M Price41.47
SMA2011.41% SMA5024.85% SMA20091.61% Trades Volume530,894 Change0.19%
Date Action Analyst Rating Change Price Target Change
May-21-24Reiterated Chardan Capital Markets Buy $31 → $42
Apr-30-24Initiated Morgan Stanley Overweight $40
Feb-20-24Initiated H.C. Wainwright Buy $36
Feb-27-23Upgrade Raymond James Outperform → Strong Buy $16 → $27
Feb-15-23Initiated Oppenheimer Outperform $34
Jan-26-23Initiated Guggenheim Buy $33
Jul-20-22Initiated Chardan Capital Markets Buy $17
Jul-12-22Initiated Raymond James Outperform $15
Oct-12-20Initiated Stifel Buy $29
Oct-12-20Initiated Piper Sandler Overweight $34
Jul-18-24 12:00PM
Jul-12-24 08:50AM
Jun-24-24 07:30AM
Jun-13-24 04:40PM
Jun-04-24 06:00AM
07:30AM Loading…
May-30-24 07:30AM
May-28-24 07:30AM
May-21-24 08:39PM
12:27PM
07:17AM
May-20-24 05:53PM
04:27PM
04:07PM
04:01PM
11:22AM
09:40AM Loading…
09:40AM
09:12AM
08:02AM
07:47AM
07:36AM
06:30AM
May-19-24 08:00AM
May-04-24 05:31AM
May-02-24 11:52PM
04:10PM
Apr-30-24 07:32AM
Mar-27-24 04:05PM
08:30AM
Mar-25-24 12:28PM
07:30AM
07:30AM Loading…
Mar-13-24 07:30AM
Mar-07-24 01:19PM
Mar-05-24 10:53AM
07:30AM
Mar-02-24 12:00AM
Feb-29-24 03:02AM
Feb-14-24 04:15PM
Feb-01-24 07:30AM
Jan-26-24 11:01PM
Jan-22-24 10:14PM
Jan-12-24 01:12PM
Jan-11-24 04:05PM
Jan-05-24 09:02AM
07:30AM
Jan-04-24 10:46PM
04:37PM
12:39PM
Jan-03-24 04:25PM
02:46PM
02:01PM
08:19AM
06:30AM
Jan-02-24 04:05PM
Nov-13-23 06:59PM
Nov-07-23 07:30AM
Oct-31-23 05:36AM
01:11AM
Oct-30-23 07:30AM
Sep-28-23 07:30AM
Sep-20-23 04:05PM
Sep-15-23 01:52PM
Sep-14-23 01:22PM
Sep-05-23 07:30AM
Aug-28-23 10:22AM
Aug-03-23 07:30AM
Jun-16-23 08:46AM
Jun-01-23 07:30AM
May-25-23 07:30AM
May-17-23 11:25AM
07:30AM
May-11-23 07:30AM
May-03-23 07:35AM
May-02-23 04:46PM
Mar-23-23 07:30AM
Mar-20-23 07:30AM
Mar-07-23 07:30AM
Mar-02-23 07:30AM
Mar-01-23 09:00AM
Feb-27-23 04:40PM
Feb-05-23 05:03AM
Jan-19-23 08:23AM
Jan-18-23 08:49AM
Jan-10-23 12:00PM
Jan-03-23 07:30AM
Dec-16-22 09:55AM
Dec-09-22 09:55AM
Dec-08-22 08:10AM
Nov-30-22 09:55AM
Nov-03-22 07:30AM
Nov-02-22 07:30AM
Oct-31-22 07:30AM
Oct-12-22 06:45AM
Oct-11-22 04:10PM
Sep-27-22 07:30AM
Sep-12-22 07:00AM
Sep-06-22 04:30PM
07:01AM
07:00AM
Aug-29-22 07:30AM
Aug-10-22 07:30AM
Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HIGH SUSANNA GATTIChief Operating OfficerJun 24 '24Option Exercise5.5410,16356,303158,955Jun 24 08:41 PM
HIGH SUSANNA GATTIChief Operating OfficerJun 24 '24Sale35.3310,163359,059148,792Jun 24 08:41 PM
HIGH SUSANNA GATTIChief Operating OfficerJun 21 '24Option Exercise5.5429,787165,020178,579Jun 24 08:41 PM
HIGH SUSANNA GATTIChief Operating OfficerJun 21 '24Sale35.0129,7871,042,843148,792Jun 24 08:41 PM
HIGH SUSANNA GATTIChief Operating OfficerJun 12 '24Option Exercise5.5440,000221,600188,792Jun 13 09:45 PM
HIGH SUSANNA GATTIChief Operating OfficerJun 12 '24Sale33.3640,0001,334,201148,792Jun 13 09:45 PM
HIGH SUSANNA GATTIChief Operating OfficerJun 11 '24Sale31.235,270164,582148,792Jun 11 07:34 PM
Farwell WildonChief Medical OfficerJun 11 '24Sale31.272,63682,428145,543Jun 11 07:41 PM
Beskrovnaya OxanaChief Scientific OfficerJun 11 '24Sale31.342,13666,942147,511Jun 11 07:42 PM
McNeill JonathanChief Business OfficerJun 11 '24Sale31.341,82357,133134,811Jun 11 07:34 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jun 11 '24Sale31.341,33141,714113,774Jun 11 07:28 PM
HIGH SUSANNA GATTIChief Operating OfficerJun 10 '24Option Exercise5.5480,000443,200234,062Jun 11 07:34 PM
HIGH SUSANNA GATTIChief Operating OfficerJun 10 '24Sale30.2480,0002,419,200154,062Jun 11 07:34 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jun 10 '24Sale30.231,59048,066115,105Jun 11 07:28 PM
Beskrovnaya OxanaChief Scientific OfficerMay 20 '24Option Exercise1.0330,42631,339180,073May 22 09:01 PM
Beskrovnaya OxanaChief Scientific OfficerMay 20 '24Sale32.9630,4261,002,751149,647May 22 09:01 PM
McNeill JonathanChief Business OfficerMay 16 '24Sale28.272,77478,420136,634May 17 09:03 PM
HIGH SUSANNA GATTIChief Operating OfficerMay 16 '24Sale28.272,73877,402154,062May 17 09:05 PM
Beskrovnaya OxanaChief Scientific OfficerMay 16 '24Sale28.272,70576,469149,647May 17 09:07 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.May 16 '24Sale28.272,58873,162116,695May 17 09:04 PM
Farwell WildonChief Medical OfficerMay 16 '24Sale28.272,38167,310148,179May 17 09:06 PM
Farwell WildonChief Medical OfficerMar 12 '24Sale25.581,03026,347150,560Mar 12 09:58 PM
Brumm Joshua TCEO & PresidentMar 11 '24Option Exercise5.5450,000277,000604,385Mar 12 09:56 PM
McNeill JonathanChief Business OfficerMar 11 '24Option Exercise5.5417,82598,750159,009Mar 13 06:04 AM
Brumm Joshua TCEO & PresidentMar 11 '24Sale25.6766,3871,704,142537,998Mar 12 09:56 PM
McNeill JonathanChief Business OfficerMar 11 '24Sale25.5019,601499,842139,408Mar 13 06:04 AM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 11 '24Sale25.282,67267,542119,283Mar 12 09:57 PM
HIGH SUSANNA GATTIChief Operating OfficerMar 11 '24Sale25.702,29258,904156,800Mar 13 06:04 AM
Beskrovnaya OxanaChief Scientific OfficerMar 11 '24Sale25.702,08153,482152,352Mar 12 09:42 PM
Farwell WildonChief Medical OfficerMar 11 '24Sale25.701,58540,734151,590Mar 12 09:58 PM
Brumm Joshua TCEO & PresidentMar 08 '24Option Exercise5.54363,3432,012,920917,728Mar 12 09:56 PM
McNeill JonathanChief Business OfficerMar 08 '24Option Exercise5.5490,000498,600231,184Mar 13 06:04 AM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 08 '24Option Exercise5.5486,252477,836208,207Mar 12 09:57 PM
Brumm Joshua TCEO & PresidentMar 08 '24Sale25.93363,3439,421,634554,385Mar 12 09:56 PM
McNeill JonathanChief Business OfficerMar 08 '24Sale26.2490,0002,361,531141,184Mar 13 06:04 AM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 08 '24Sale26.2286,2522,261,465121,955Mar 12 09:57 PM
HIGH SUSANNA GATTIChief Operating OfficerMar 08 '24Sale26.6727,199725,344159,092Mar 13 06:04 AM
Farwell WildonChief Medical OfficerMar 07 '24Sale25.869,921256,585153,175Mar 11 09:52 PM
Brumm Joshua TCEO & PresidentMar 07 '24Sale25.859,086234,873554,385Mar 11 09:57 PM
McNeill JonathanChief Business OfficerMar 07 '24Sale25.852,43462,919141,184Mar 11 09:50 PM
Beskrovnaya OxanaChief Scientific OfficerMar 07 '24Sale25.852,37361,342154,433Mar 11 09:56 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 07 '24Sale25.852,27358,757121,955Mar 11 09:45 PM
HIGH SUSANNA GATTIChief Operating OfficerMar 07 '24Sale25.851,59141,127186,291Mar 11 09:56 PM
Brumm Joshua TCEO & PresidentMar 01 '24Option Exercise5.5494,480523,419657,951Mar 01 09:38 PM
McNeill JonathanChief Business OfficerMar 01 '24Option Exercise0.7324,26017,710167,878Mar 01 09:37 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 01 '24Option Exercise1.039,3119,590133,539Mar 01 09:37 PM
Brumm Joshua TCEO & PresidentMar 01 '24Sale29.0494,4802,743,718563,471Mar 01 09:38 PM
Rhodes Jason PDirectorMar 01 '24Sale30.0546,5341,398,347847,388Mar 05 05:08 PM
Atlas Venture Opportunity Fund10% OwnerMar 01 '24Sale30.0529,435884,5221,458,691Mar 05 05:07 PM
McNeill JonathanChief Business OfficerMar 01 '24Sale28.6324,260694,495143,618Mar 01 09:37 PM
Atlas Venture Opportunity Fund10% OwnerMar 01 '24Sale30.0517,099513,825847,388Mar 05 05:07 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 01 '24Sale28.259,311262,999124,228Mar 01 09:37 PM
Brumm Joshua TCEO & PresidentFeb 29 '24Option Exercise5.545,52030,581568,991Mar 01 09:38 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Feb 29 '24Option Exercise1.033,4293,532127,657Mar 01 09:37 PM
McNeill JonathanChief Business OfficerFeb 29 '24Option Exercise0.734,2683,116147,886Mar 01 09:37 PM
Brumm Joshua TCEO & PresidentFeb 29 '24Sale27.505,520151,800563,471Mar 01 09:38 PM
McNeill JonathanChief Business OfficerFeb 29 '24Sale27.504,268117,370143,618Mar 01 09:37 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Feb 29 '24Sale27.503,42994,298124,228Mar 01 09:37 PM
Rhodes Jason PDirectorFeb 28 '24Sale24.84190,9204,741,804864,487Feb 28 07:15 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 28 '24Sale24.84154,6743,841,5765,698,091Feb 28 07:13 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 28 '24Sale24.8436,246900,228864,487Feb 28 07:13 PM
Rhodes Jason PDirectorFeb 27 '24Sale24.41368,6998,998,426877,806Feb 28 07:15 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 27 '24Sale24.41298,7027,290,0885,852,765Feb 28 07:13 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 27 '24Sale24.4169,9971,708,338877,806Feb 28 07:13 PM
Rhodes Jason PDirectorFeb 26 '24Sale23.72248,2195,886,673903,527Feb 28 07:15 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 26 '24Sale23.72201,0954,769,0966,151,467Feb 28 07:13 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 26 '24Sale23.7247,1241,117,577903,527Feb 28 07:13 PM
Rhodes Jason PDirectorFeb 23 '24Sale22.70196,9284,470,266920,843Feb 23 06:59 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 23 '24Sale22.70159,5423,621,6036,352,562Feb 23 06:58 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 23 '24Sale22.7037,386848,662920,843Feb 23 06:58 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 22 '24Sale22.66119,3602,704,6986,512,104Feb 23 06:58 PM
Rhodes Jason PDirectorFeb 22 '24Sale22.66119,3602,704,6986,512,104Feb 23 06:59 PM
Rhodes Jason PDirectorFeb 21 '24Sale22.57184,5014,164,8176,631,464Feb 23 06:59 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 21 '24Sale22.57184,5014,164,8176,631,464Feb 23 06:58 PM
Rhodes Jason PDirectorFeb 20 '24Sale22.72169,5393,852,6536,815,965Feb 20 06:36 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 20 '24Sale22.72169,5393,852,6536,815,965Feb 20 06:35 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 16 '24Sale23.14162,7073,765,0406,985,504Feb 20 06:35 PM
Rhodes Jason PDirectorFeb 16 '24Sale23.14162,7073,765,0406,985,504Feb 20 06:36 PM
Rhodes Jason PDirectorFeb 15 '24Sale23.89177,9064,249,6007,148,211Feb 20 06:36 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 15 '24Sale23.89177,9064,249,6007,148,211Feb 20 06:35 PM
Farwell WildonChief Medical OfficerFeb 12 '24Sale25.075,493137,710163,503Feb 14 04:27 PM
McNeill JonathanChief Business OfficerJan 26 '24Option Exercise0.7320,00014,600163,618Jan 26 07:48 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 26 '24Option Exercise1.0313,00013,390137,228Jan 26 07:47 PM
McNeill JonathanChief Business OfficerJan 26 '24Sale24.5320,000490,510143,618Jan 26 07:48 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 26 '24Sale24.3413,000316,420124,228Jan 26 07:47 PM
Farwell WildonChief Medical OfficerJan 26 '24Sale25.001002,500168,996Jan 26 07:49 PM
Kersten DirkDirectorJan 09 '24Buy17.501,714,28529,999,9886,416,793Jan 11 04:31 PM
Brumm Joshua TCEO & PresidentJan 04 '24Option Exercise5.16218,5361,127,092803,507Jan 04 09:49 PM
Beskrovnaya OxanaChief Scientific OfficerJan 04 '24Option Exercise1.0322,67423,354199,259Jan 04 09:48 PM
McNeill JonathanChief Business OfficerJan 04 '24Option Exercise0.732,0091,467145,627Jan 04 09:47 PM
Brumm Joshua TCEO & PresidentJan 04 '24Sale18.51218,5364,045,958584,971Jan 04 09:49 PM
Beskrovnaya OxanaChief Scientific OfficerJan 04 '24Sale18.1342,453769,673156,806Jan 04 09:48 PM
McNeill JonathanChief Business OfficerJan 04 '24Sale18.042,00936,242143,618Jan 04 09:47 PM
Brumm Joshua TCEO & PresidentJan 03 '24Option Exercise1.0351,18352,718636,154Jan 04 09:49 PM
Beskrovnaya OxanaChief Scientific OfficerJan 03 '24Option Exercise1.0345,32646,686221,911Jan 04 09:48 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 03 '24Option Exercise1.0313,00013,390137,228Jan 04 09:46 PM
McNeill JonathanChief Business OfficerJan 03 '24Option Exercise0.7317,99113,133161,609Jan 04 09:47 PM
Brumm Joshua TCEO & PresidentJan 03 '24Sale19.2851,183986,957584,971Jan 04 09:49 PM
Beskrovnaya OxanaChief Scientific OfficerJan 03 '24Sale18.9845,326860,313176,585Jan 04 09:48 PM
McNeill JonathanChief Business OfficerJan 03 '24Sale18.7417,991337,062143,618Jan 04 09:47 PM